Syndecan 1 is a therapeutic target for KRAS-driven pancreatic cancer

被引：0
|
作者：
Takeda, Mitsunobu
Yang, Zecheng
Theardy, Madeline S.
Sorokin, Alexey
Coker, Oluwadara
Chen, Shuaitong
Vien, Long T.
Bover, Laura
Ying, Haoqiang
Kopetz, Scott
Yao, Wantong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-IA-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA-08
引用
收藏
页数：3
相关论文
共 50 条
  • [1] KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma
    Than, Minh T.
    O'Hara, Mark
    Stanger, Ben Z.
    Reiss, Kim A.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (10) : 1378 - 1388
  • [2] Cellular 8-oxodGTPase activity as a novel target in KRAS-driven pancreatic cancer
    Mateo-Victoriano, Beatriz
    Zhang, Ling
    Samaranayake, Govindi
    Due, Cassie
    Troccoli, Clara
    Zaias, Julia
    Nagathihalli, Nagaraj
    Mohsen, Michael
    Kool, Eric
    Rai, Priyamvada
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 192
  • [3] Syndecan-1 is required for oncogenic Kras-driven PDAC tumorigenesis and maintenance
    Yao, Wantong
    Wang, Wei
    Taguchi, Ayumu
    Kapoor, Avnish
    Momin, Amin
    Jiang, Hong
    Rose, Johnathon
    Celiktas, Muge
    Deem, Angela
    Hanash, Samir
    DePinho, Ronald
    Ying, Haoqiang
    Draetta, Giulio
    CANCER RESEARCH, 2015, 75
  • [4] Zeb1 in Stromal Myofibroblasts Promotes Kras-Driven Development of Pancreatic Cancer
    Sangrador, Irene
    Molero, Xavier
    Campbell, Fiona
    Franch-Exposito, Sebastia
    Rovira-Rigau, Maria
    Samper, Esther
    Dominguez-Fraile, Manuel
    Fillat, Cristina
    Castells, Antoni
    Vaquero, Eva C.
    CANCER RESEARCH, 2018, 78 (10) : 2624 - 2637
  • [5] Loss of KDM5A supports KRAS-driven pancreatic cancer
    Chen, Jasper R.
    Han, Jincheng
    Taniguchi, Cullen M.
    DePinho, Ronald A.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Loss of KDM5A supports KRAS-driven pancreatic cancer
    Chen, Jasper
    Han, Jincheng
    DePinho, Ronald A.
    Taniguchi, Cullen M.
    CANCER RESEARCH, 2024, 84 (02)
  • [7] Iron out KRAS-driven cancer
    Lei, Guang
    Gan, Boyi
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (04):
  • [8] Treatment modalities in KRAS-driven cancer
    Tyson, Darren R.
    Singh, Neetu
    Bhavar, Prashant K.
    Sarma, Partha Pratim
    Surampudi, Uday Kumar
    Katike, Sathish
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [9] Mucin 5ac as a potential therapeutic target for KRAS-driven lung adenocarcinoma
    Torrez, Walter V. Velasco
    Deng, Shanshan
    Ramos-Castaneda, Marco A.
    Del Aguila-Soto, Segundo W.
    Moghaddam, Seyed
    CANCER RESEARCH, 2020, 80 (16)
  • [10] Maintenance of acinar cell differentiation prevents KRAS-driven pancreatic cancer initiation
    Krah, Nathan M.
    Yugawa, Deanne E.
    Straley, Julie A.
    Narayanan, Shuba M.
    Azevedo-Pouly, Ana C.
    Murtaugh, L. Charles
    CANCER RESEARCH, 2017, 77 (22)
12345